DUBLIN, Oct. 21, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/p7f6tr/global_infusion) has announced the addition of the "Global Infusion Pumps & Accessories Market Assessment & Forecast: 2015-2019" report to their offering.

Chronic pain is a worldwide burden that is estimated to have a burden of over 600 billion dollars in United States alone, whereas cancer and diabetes have an annual burden of US$ 243.0 billion and US$ 188.0 billion.

This report provides an in-depth perspective on the revenue generated through demand from end-users such as Hospitals, HomeCare, Clinics and Infusion Centers or Infusion Pharmacies. It also provides another perspective of demand of infusion pumps market by applications such as Pain Management, Chemotherapy or Oncology, Infection Management (infusion of antimicrobial agents), Nutrition Management (Enteral and TPN), Insulin or Diabetes Management and Pediatric Infusion. Diabetes, cancer and chronic pain are long term illnesses that are increasing in incidence each year. In recent years the incidence and prevalence of diabetes has reached exponential levels with a global prevalence pegged by the WHO to be 9% worldwide among adults only. There is also a growing number of adolescent diabetes occurring worldwide.

The rising population of diabetes coupled by increasing adoption of insulin pumps by Type II diabetics will propel the market for these devices in coming years.  Increasing number of trauma patients are opting for implantable infusion pumps or IBT therapies. The combined rise of diabetes, cancer and chronic pain will push the market for infusion pumps significantly through the forecast period and even beyond it.

With the advent of infusion pumps the medical community expected to reduce the number of errors, however even with all the medication administration errors, the single greatest source was human error. The most prominent disadvantage till recent times was that infusion pumps could not read the age, weight and other parameters of the patient from medical records in order to create filters and barriers for medication administration. The infusion pumps have to be programmed for use each time which have been causing massive errors where people have tragically died due to overdose of drugs. Close to 3 million people are estimated to rely on home infusions each year in United States alone and the trend is expected to be the same in Europe as well.

Increasing demand for healthcare services and products to be reached in patient comfort zones will continue in coming years driving the growth of the market. The Medicare Home Infusion Site of Care Act of 2015 provides a pathway for reimbursement for the professional services, supplies and equipment associated with infusion therapy in the home under Medicare Part B.

Commercial and research activities of over 40 players in the infusion devices market were analysed within this report. Infusion has been used in medicine since eons but has advanced very quickly in the last 20-30 odd years. There have been many strategies followed by companies to market their products and increase overall presence in various segments. Due to the integral working of pharmaceutical products and electronic devices together, the infusion pumps market lies at the overlap of the healthcare market which is broadly categorized into medical devices and pharmaceuticals. It is one of the largest drug delivery technologies today. The Global Infusion Pumps Market is highly fragmented.

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Précis

Chapter 3 Market Dynamics

Chapter 4 Infusion Pumps & Accessories - Global Market Size Assessment, by Products, Forecast: 2015 - 2019

Chapter 5 Infusion Pumps - Global Market Size Assessment, by End-Users, Forecast: 2015 - 2019

Chapter 6 Infusion Pumps - Global Market Size Assessment, by Applications, Forecast: 2015 - 2019

Chapter 7 Infusion Pumps & Accessories - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019

Chapter 8 Key Players Analysis: Infusion Pumps Market, 2014 (%)

- 3AF Group

- Akas Medical

- Arcomed AG

- Ascor SA

- B Braun

- Baxter

- Caesarea Medical Electronics

- CareFusion

- CME Medical

- Codan Argus

- Codman & Shurtleff)

- Diaken Medical Co Ltd

- Flowonix

- Fresnius Kabi

- Halyard Medical

- Hospira (Pfizer)

- Insulet Corporation

- Johnson & Johnson (Animas

- KD Scientific

- Medtronic Inc

- Micrel Medical Devices

- Mindray Medical

- Moog Medical

- Pancreum

- Plenumtech

- Roche

- Schiller AG

- Smiths Medical

- Tandem

- Tricumed

- TSS Medical

- Unilife

- Zyno Medical

For more information visit

http://www.researchandmarkets.com/research/p7f6tr/global_infusion

Media Contact:

Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets